RxDoctor Payments Data

Laurie Davis

Family · East Ridge, TNNPI 1659332385

Payments from drug & device makers

$6,936in general payments, 2019–2025

Across 319 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$696
  • AbbVie$645
  • AstraZeneca$631
  • Otsuka America Pharmaceutical, Inc.$532
  • Lilly USA, LLC$394
  • GSK$339
  • plus $4K from 44 others

What the payments were for

  • Food & beverage$6,936100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,936 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$18,051
Medicare patients
275
Services billed
900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$41,826
MounjaroTirzepatide31$31,279
FarxigaDapagliflozin Propanediol38$28,385
EliquisApixaban22$15,906
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$15,820
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog22$11,705
SynjardyEmpagliflozin/Metformin Hcl13$3,716
Tiotropium Bromide12$2,984
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide20$1,488
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,368
Gabapentin44$1,141
Duloxetine Hcl60$979
Bupropion XlBupropion Hcl27$942
Albuterol Sulfate HfaAlbuterol Sulfate40$896
Losartan Potassium87$857

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$696$41,82639 claims
Lilly USA, LLCMounjaro$394$31,27931 claims
AstraZenecaFarxiga$631$28,38538 claims
PfizerEliquis$143$15,90622 claims
GSKTrelegy Ellipta$339$15,82019 claims
Boehringer IngelheimSynjardy$247$3,71613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in East Ridge

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →